Orexo eyes real-world testing of its modia opioid use disord...

Orexo will start a new study of its modia app – used to treat people with opioid use disorder – to test how it performs in real-world settings.

Digital therapies for opioid use disorder need more data, sa...

There isn’t enough evidence to suggest that digital therapies for people with opioid use disorder (OUD) can improve on standard interventions, according to the Institute for Clinical and Ec

Purdue to pay $8.3bn after admitting criminal charges in opi...

After years of legal wrangling, Purdue Pharma has agreed a deal to resolve litigation about its role in the US opioid epidemic that will cost it up to $8.3 billion.

Orexo eyes opioid use disorder app launch before year-end

Sweden’s Orexo says its opioid use disorder (OUD) digital therapeutic – now christened Modia – is on course for a launch before the end of the year in the US.

After final $600M opioid settlement, Indivior looks to the f...

UK drugmaker Indivior looks finally to have put years of uncertainty over its exposure to opioid litigation in the US behind it, after agreeing a $600 million settlement.

Mallinckrodt proposes $1.6bn deal to settle opioid litigatio...